By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ajinomoto Althea Inc. 

11040 Roselle Street

San Diego  California  92121  U.S.A.
Phone: 858-882-0123 Fax: 858-882-0133


SEARCH JOBS

Ajinomoto Althea, located in San Diego, CA, is a contract development and manufacturing organization that specializes in cGMP manufacturing, analytical development, aseptic filling into vials & syringes, and protein delivery technology for recombinant protein and parenteral products. In a single location, Althea has the capacity to meet your early-stage and commercial requirements.

Key Services:

• Cell Line Development
• Process Development
• cGMP Protein & DNA Plasmid Production
• Analytical Method Development
• Lyophilization Cycle Development
• Sterile Vial Filling
• Sterile Syringe Filling

Protein Formulation Technology - Crystalomics™

• High Concentration Formulations
• Sustained Release Formulations
• Proven Technology
• Proven cGMP Manufacturability at Scale

Since its founding in 1998, Althea's manufacturing facilities have been inspected by the FDA in 2005, 2008, 2011 (2), 2012 & 2013, and by over 30 different QPs. To-date, Althea’s cGMP facilities have produced >300 cell banks, >160 cGMP protein & plasmid DNA lots, and >1,700 cGMP fill & finish lots. Althea has the experience, expertise, capacity, and flexibility to serve as your strategic partner for your drug development and manufacturing needs.


Key Statistics


Email: info@altheatech.com
Ownership: Private

Web Site: Ajinomoto Althea Inc.
Employees:
Symbol: 
 









Company News
Ajinomoto Completes Acquisition of Althea Technologies, Inc. 4/5/2013 9:00:05 AM
Ajinomoto Agrees to Acquire Althea Technologies, Inc. for $175 Million 3/6/2013 7:37:04 AM
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production 2/26/2013 9:32:33 AM
Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen 10/24/2012 10:30:21 AM
Althea Technologies, Inc. Announces Expanded Roles for Key Executives 9/24/2012 10:41:50 AM
Althea Technologies, Inc. Appoints Dr. Dennis Fenton as Chairman of Its Scientific Advisory Board 6/19/2012 10:35:24 AM
Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing 5/2/2012 10:33:47 AM
Allena Pharmaceuticals, Inc. Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies, Inc. 3/28/2012 7:28:53 AM
Althea Technologies, Inc. Appoints Martha J. Demski as Senior Vice President and Chief Financial Officer 9/8/2011 5:55:58 AM
Althea Technologies, Inc. Hosts Health and Wellness Week 8/11/2011 6:14:37 AM
12345
//-->